Comparison

CD105 [MEM-226]

Item no. 20-272-192402
Manufacturer GENWAY
Amount 0.1 mg
Category
Type Antibody
Applications WB, IP
Clone MEM-226
Specific against other
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias GWB-C3E9F0
Similar products 20-272-192402
Available
Genway ID:
GWB-C3E9F0
Clone:
MEM-226
Isotype:
IgG1
Immunogen:
Recombinant full length protein (Human). Expressed in vaccinia virus containing CD105 cDNA.
Antigen Species:
Human
Specificity:
This antibody recognises CD105 antigen.
Target:
CD105
Localization:
Cell Membrane
Concentration:
1 mg/ml
Purification Note:
Purified from ascites by protein A-affinity chromatography. Storage
Buffer:
Phosphate buffered saline pH 7. 4 containing 15mM sodium azide
Application Note:
FACS: Use at an assay dependant concentration. IP: Use at an assay dependant concentration. WB: Use at an assay dependant concentration. Use under non-reducing conditions. Not tested in other applications. Optimal dilutions/concentrations should be determined by the end user. Cellular
Localization:
Cell Membrane Endoglin also called CD105 is a homodimeric membrane glycoprotein primarily associated with human vascular endothelium. It is also found on bone marrow proerythroblasts activated monocytes and lymphoblasts in childhood leukemia. Endoglin is a component of the transforming growth factor beta receptor complex as it binds TGFB1 with high affinity.
Function:
Major glycoprotein of vascular endothelium. May play a critical role in the binding of endothelial cells to integrins and/or other RGD receptors.
Subunit:
Homodimer that forms an heteromeric complex with the signaling receptors for transforming growth factor-beta: TGF-beta receptors I and/or II. It is able to bind TGF-beta 1 and 3 efficiently and TGF-beta 2 less efficiently. Interacts with TCTEX1D4.
Subcellular Location:
Membrane; Single-pass type I membrane protein.
Tissue Specificity:
Endoglin is restricted to endothelial cells in all tissues except bone marrow.
Disease:
Defects in ENG are the cause of hereditary hemorrhagic telangiectasia type 1 (HHT1) [MIM:187300 108010]; also known as Osler-Rendu-Weber syndrome 1 (ORW1). HHT1 is an autosomal dominant multisystemic vascular dysplasia characterized by recurrent epistaxis muco-cutaneous telangiectases gastro-intestinal hemorrhage and pulmonary (PAVM) cerebral (CAVM) and hepatic arteriovenous malformations; all secondary manifestations of the underlying vascular dysplasia. Although the first symptom of HHT1 in children is generally nose bleed there is an important clinical heterogeneity.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 0.1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close